U.S. hospices lack standard for benzodiazepines, antipsychotics use: study
By
Alicia Lasek
Mar 28, 2023
Investigators have found significant variation in what is considered clinically appropriate use of these drugs for the U.S. hospice population.
Catheter-linked UTIs more likely to resist antibiotics, large study finds
By
Alicia Lasek
Mar 28, 2023
The results emphasize the need for urine sampling and culturing before treating catheter-associated UTIs, and the importance of considering therapeutic alternatives, investigators say.
FDA aims to expand the use of salt substitutes in processed foods
By
Alicia Lasek
Mar 28, 2023
The FDA wants to allow manufacturers of regulated, everyday foods to replace salt with “safe and suitable” substitutes.
Clinical briefs for Tuesday, March 28
By
Alicia Lasek
Mar 28, 2023
CMS tightens guidance for nursing home dialysis providers … CDC: TB cases rose in 2022, but haven’t hit prepandemic levels … FDA panel backs accelerated approval for Biogen’s ALS drug … Low...
CDC: C. auris spreading at ‘alarming’ rate in U.S. healthcare facilities
By
Alicia Lasek
Mar 22, 2023
Drug-resistant Candida auris, a known threat to nursing homes, has spread rapidly, and a growing number of cases are resistant to first-line treatment, federal researchers report.
Post-op delirium tied to faster cognitive decline in 6-year study
By
Alicia Lasek
Mar 22, 2023
Postoperative delirium may speed the rate of cognitive decline in older adults by 40% within six years after a major elective surgery, a new study has found
Clinical briefs for Wednesday, March 22
By
Alicia Lasek
Mar 22, 2023
AARP: Many older adults still shun vaccines, despite concerns over illnesses … Hydrocortisone use cuts mortality in severe pneumonia, physicians find … About 1 in 3 medical services users don’t see...
Hybrid immunity ups residents’ defense against severe COVID-19, study finds
By
Alicia Lasek
Mar 20, 2023
Nursing home residents infected with COVID-19 prior to vaccination had the strongest protection against severe disease when compared to their peers without such hybrid immunity.
Large EHR study confirms Paxlovid works best within 5-day time window
By
Alicia Lasek
Mar 20, 2023
Protection against severe outcomes soared to 80% when the drug was dispensed within five days of symptom onset, compared with 54% efficacy outside that time frame, investigators found.
Clinical briefs for Tuesday, March 21
By
Alicia Lasek
Mar 20, 2023
LeadingAge: MA program failures jeopardize health of nearly 30 million older adults … Behavioral health is crucial ingredient in new Michigan home care program … Patients prefer to see test results...